WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
Earlier this year the Therapeutic Goods Administration (TGA) halted the sale of 21 sunscreen products in Australia following ...
In this interview, Dr. Robert Beal discusses how advances in digital polymerase chain reaction technologies are reshaping ...
Mongabay News on MSN
The lab-in-a-backpack busting illegal shark fins: Interview with Diego Cardeñosa
Diego Cardeñosa always knew he wanted to study sharks. But when he started his Ph.D., he had to make a choice: tagging sharks ...
Health and Me on MSN
WHO approves two COVID-19 rapid antigen tests, check the details here
SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...
Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes.
In New York, cases of flu, RSV and COVID have spiked since Thanksgiving, and doctors expect that trend to continue with more ...
In this Q&A, Kevin Kelly hares what it took to get here and why he sees PCR as both a critical environmental solution and a ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software ...
Phoenix, Ariz, December 11th, 2025, FinanceWireWith periodontal disease affecting more than four in ten American adults and ...
Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback